Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02600234 · ClinicalTrials.gov registry record · NA
Reduce Lap-hf Randomized Trial I
A NA study of Heart Failure, sponsored by Corvia Medical.
- Active
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 20
- Study locations
NCT02600234: Active NA study of Heart Failure, sponsored by Corvia Medical.
NCT02600234 is a NA study of Heart Failure that is active but no longer recruiting, run by Corvia Medical. The registered enrollment target is 44 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02600234, a NA study of Heart Failure, is active but no longer recruiting, sponsored by Corvia Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 20
- Study locations
Study Summary
A study to evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure.
Conditions Studied
Interventions
- DEVICE Inter-Atrial Shunt Device
- OTHER Intracardiac Echo
Study Locations (20)
New York
- Columbia University Medical Center/NewYork Presbyterian Hospital - New York
- Mt. Sinai Hospital - New York
- New York University - New York
Other
- The Alfred Hospital - Melbourne
- OLVZ Aalst - Aalst
- UMC Groningen - Groningen
Illinois
- Northwestern University - Chicago
- Evanston Northshore Healthcare - Evanston
Louisiana
- Cardiovascular Institute of the South - Houma
- Ochsner Medical Center - New Orleans
Ohio
- Ohio Health - Columbus
- Ohio State University College of Medicine - Columbus
Arizona
- University of Arizona College of Medicine - Tucson
Connecticut
- Yale University - New Haven
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-12 |
| Est. Completion | 2026-08 |
| Phase | NA |
What the registry record for NCT02600234 still lists
NCT02600234 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Inter-Atrial Shunt Device is the first listed.
NCT02600234 names 20 study sites across 13 states, led by New York, Other, Illinois.
Frequently Asked Questions
What is clinical trial NCT02600234 about?
NCT02600234 is a clinical study titled "Reduce Lap-hf Randomized Trial I". A study to evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure.
What is the current status of trial NCT02600234?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2015-12. Estimated completion is 2026-08.
What conditions does trial NCT02600234 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT02600234?
The interventions under investigation include: Inter-Atrial Shunt Device (DEVICE), Intracardiac Echo (OTHER).
Who is sponsoring clinical trial NCT02600234?
This trial is sponsored by Corvia Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02600234 being conducted?
This trial has 20 study locations across Arizona, Connecticut, Illinois, Louisiana, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02600234's enrollment target sits among peer trials
44 298th of 397 higher than 100 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia